AllianceBernstein
NEOS

AllianceBernstein’s Neos Therapeutics, Inc NEOS Stock Holding History

AllianceBernstein’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,500
Closed -$61K – 3216
2019
Q1 		$61K Sell
23,500
-5,100
-18% -$12K ﹤0.01% 3071
2018
Q4 		$47K Sell
28,600
-7,900
-22% -$22.2K ﹤0.01% 3064
2018
Q3 		$177K Hold
36,500
– – ﹤0.01% 3008
2018
Q2 		$228K Buy
36,500
+6,900
+23% +$51.4K ﹤0.01% 2918
2018
Q1 		$246K Hold
29,600
– – ﹤0.01% 2771
2017
Q4 		$302K Buy
29,600
+7,600
+35% +$72.9K ﹤0.01% 2708
2017
Q3 		$201K Hold
22,000
– – ﹤0.01% 2943
2017
Q2 		$161K Buy
+22,000
New +$166K ﹤0.01% 3037

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein's NEOS Position: Q2 2019 in Review

AllianceBernstein sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 23,500 shares — an estimated $61K sold.

AllianceBernstein first reported a position in NEOS in Q2 2017 and held it in 8 quarters. The position peaked at $302K in Q4 2017. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • AllianceBernstein reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • AllianceBernstein sold 23,500 Neos Therapeutics, Inc shares in Q2 2019, an estimated $61K.
  • AllianceBernstein first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 8 quarters.
  • AllianceBernstein's Neos Therapeutics, Inc position peaked at $302K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.